100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
ERHS 569 Exam 1 Questions & Answers 2024/2025 R148,69   Add to cart

Exam (elaborations)

ERHS 569 Exam 1 Questions & Answers 2024/2025

 4 views  0 purchase
  • Course
  • ERHS 569
  • Institution
  • ERHS 569

ERHS 569 Exam 1 Questions & Answers 2024/2025 GLP 10 principles - ANSWERS1. Test facility organization 2. Quality assurance program ities 4. apparatus, material, reagents 5. test systems 6. test and reference items 7. SOP's 8. performance of the study 9. reporting of study results 10....

[Show more]

Preview 2 out of 6  pages

  • November 20, 2024
  • 6
  • 2024/2025
  • Exam (elaborations)
  • Questions & answers
  • ERHS 569
  • ERHS 569
avatar-seller
ERHS 569 Exam 1 Questions & Answers
2024/2025

GLP 10 principles - ANSWERS1. Test facility organization

2. Quality assurance program

3.facilities

4. apparatus, material, reagents

5. test systems

6. test and reference items

7. SOP's

8. performance of the study

9. reporting of study results

10. storage and retention of records and materials



1902 Biologics Control Act - ANSWERSEnsures purity & safety of serums, vaccines.

-caused by diphtheria epidemic



1906 Pure Food and Drug Act - ANSWERSProhibits the sale and transport of adulterated or mislabeled
food, drinks and drugs.

Prohibits the mislabeling and misbranding of products.



FDA approval of a drug steps - ANSWERS1. preclinical and IND submitted

2. clinical trials phase 1

3. clinical trials phase 2

4. clinical trials phase 3

5. NDA

6. phase 4 trials

, Clinical trials phase I - ANSWERSParticipants: 20-100 can be healthy or people with the disease trying to
treat



Study length: several months



Primary purpose: -determine safety in humans

-figure out dosage (trying out the NOAEL's and LOAEL's)

-best route of administration

-best aim with fewest side effects



70% get past this phase



how much of the drug is measured in the blood after admin?



Phase II Trials - ANSWERSNumber of participants: 100's participants have the disease trying to treat



Study length: several months-2 years



Primary purpose:

-additional safety data

-determine efficacy and side effects

-optimal dose

-best route of administration

-maximize benefits minimize risk



ONLY 33% GET PAST THIS PHASE



Phase III Trials - ANSWERSNumber of participants: 300-3000 people

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through EFT, credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying this summary from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller Bensuda. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy this summary for R148,69. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

66579 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy summaries for 14 years now

Start selling
R148,69
  • (0)
  Buy now